Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Cohorts 1 and 2: chronic genotype 1 or 3 HCV infection
Cohort 3: chronic genotype 1 or 4 HCV infection
HCV RNA ≥ 10\^4 IU/mL at screening
Screening labs within defined thresholds
Cirrhosis determination at screening
You may not be if
Females who are pregnant or nursing or males who have a pregnant partner
Prior null response to pegylated interferon (Peg-IFN)+RBV therapy (Cohorts 1 and 2) or for individuals with cirrhosis, prior treatment failure with IFN-based therapy not resulting from treatment intolerance (Cohort 3)
Current of prior history of hepatic decompensation
Infection with hepatitis B virus (HBV) or HIV
History of clinically significant illness (including psychiatric or cardiac) or any other medical disorder that may interfere with individual's treatment and/or adherence to the protocol